What is COR Clinical Research?
COR Clinical Research is a dedicated research facility to find new medical treatments, new medications and improving current medication usage to provide more options for treating medical diseases and disorders throughout our communities.
The Primary Investigator Clinton N. Corder Ph.D., M.D. has more than 30 years experience in clinical research and has conducted more than 300 clinical trials throughout his career. The co-investigators at COR Clinical Research also have extensive experience in conducting research studies. COR Clinical Research is dedicated to the advancement of new medical treatments.
COR Clinical Research conducts Phase I through Phase IV clinical trials. An Investigational Review Board (IRB) and the U.S. Food and Drug Administration (FDA) regulate each study.
Qualification for patient participation in a study is determined by inclusion and exclusion criteria established for each study. The safety and best interest of our patients is our number one concern; therefore, when we select patients, careful consideration is made prior to their enrollment in the study. Patient participation in a study is always voluntary and the patient can withdraw at anytime.
In order to establish better medical treatment, medical research is necessary. At COR, we are dedicated to finding a New Wave For Your Health.